|
ALDH6A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99840144432528E-15 |
| Normal-vs-Stage2 |
4.283000E-03 |
| Normal-vs-Stage3 |
1.81654691289168E-12 |
| Normal-vs-Stage4 |
6.0507154842071E-14 |
| Stage1-vs-Stage2 |
6.695500E-03 |
| Stage1-vs-Stage3 |
7.106400E-02 |
| Stage1-vs-Stage4 |
1.954440E-02 |
| Stage2-vs-Stage3 |
5.835400E-04 |
| Stage2-vs-Stage4 |
2.202100E-04 |
| Stage3-vs-Stage4 |
5.330800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.78013201138583E-13 |
| Normal-vs-AfricanAmerican |
7.47030004522031E-09 |
| Normal-vs-Asian |
2.02571293073106E-12 |
| Caucasian-vs-AfricanAmerican |
4.895000E-01 |
| Caucasian-vs-Asian |
3.418600E-01 |
| AfricanAmerican-vs-Asian |
1.572780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.99760216648792E-15 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
2.233400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63036251166204E-12 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
1.35810251933322E-11 |
| Normal-vs-Age(81-100Yrs) |
8.371100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.548200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.813600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.966600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.390000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.098600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.839200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.260800E-03 |
| Classical-VS-Follicular |
2.2305999999972E-05 |
| Classical-VS-Other |
5.708000E-01 |
| Classical-VS-Normal |
8.57869331127858E-13 |
| Tall-VS-Follicular |
5.46170000337298E-08 |
| Tall-VS-Other |
5.119600E-01 |
| Tall-VS-Normal |
1.62680979798324E-12 |
| Follicular-VS-Other |
3.595500E-03 |
| Follicular-VS-Normal |
4.760700E-03 |
| Other-VS-Normal |
3.448800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24570020965109E-10 |
| Normal-vs-N1 |
1.62647673107585E-12 |
| N0-vs-N1 |
3.59109999999996E-05 |
|
|
